VGXI’s Statement on the Recent Litigation Involving Inovio Pharmaceuticals, Inc. (“Inovio”) in Pennsylvania State Court
Update June 26, 2020: VGXI and GeneOne are pleased with the court’s decision in our favor… Read More »
VGXI Enables Rapid GMP DNA Manufacturing Timeline for Geneos Therapeutics Personalized Cancer Immunotherapy
VGXI, Inc., Geneos Therapeutics’ CDMO partner, completes manufacturing of first GMP Lot under Clinical Manufacturing Supply… Read More »
News article released this week by the Conroe Economic Development Council announced VGXI’s planned 240,000 square-foot… Read More »
For more information
Who We Are
VGXI, Inc. is a leading contract manufacturer of DNA plasmids. We deliver flexibility, experience, reliability and value to our clients’ challenging programs. The company’s cGMP and non-cGMP products have passed rigorous international regulatory reviews. VGXI’s patented manufacturing process and cGMP production facilities give us the ability to work with your unique requirements.